| 153 | 0 | 79 |
| 下载次数 | 被引频次 | 阅读次数 |
胃癌术后化疗患者因手术直伤脾胃,化疗亦损正气,脾胃无力生荣,又有药毒内聚,荣气难抵骨髓,骨髓失其荣养难以化血,故致骨髓抑制。认为中焦枢机颓败、荣气周流失职、精髓失于荣养为病机核心,临证以升陷汤合当归补血汤为主补益中焦、提振中气,解决荣气不足之本;以复方丹参饮加减行气化瘀、解毒通络,解决荣气难抵骨髓之困;以大补元煎合二至丸加减方为基培本充髓,调养骨髓化生血液。
Abstract:Patients with gastric cancer undergoing postoperative chemotherapy often develop myelosuppression due to direct injury to the spleen and stomach caused by surgery,depletion of healthy qi by chemotherapy,impaired generation of ying(荣) qi due to spleen and stomach deficiency,and the accumulation of drug toxicity,which prevents ying qi from reaching and nourishing the bone marrow.Consequently,the bone marrow loses its nourishment and becomes unable to generate blood,leading to myelosuppression.This paper proposes that the core pathogenesis involves failure of the middle jiao(焦) pivot function,dysfunction of ying qi circulation,and insufficient nourishment of essence and marrow.Accordingly,Shengxian Decoction(升陷汤) combined with Danggui Buxue Decoction(当归补血汤) is used as the principal prescription to tonify the middle jiao and uplift center qi,thereby remedying the fundamental insufficiency of ying qi.Modified Compound Danshen Decoction(复方丹参饮) is applied to promote qi circulation,resolve stasis,remove toxin,and unblock collaterals,thereby resolving the obstruction preventing ying qi from reaching the bone marrow.Modified Dabuyuan Decoction(大补元煎) combined with Erzhi Pill(二至丸) is taken as the foundational formula to cultivate the root,replenish marrow,thereby modulating hematopoiesis in bone marrow.
[1]Ajani J A, D'Amico T A, Bentrem D J, et al. Gastric cancer, version 2. 2025, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2025, 23(5):169-191.
[2]中国临床肿瘤学会(CSCO)中西医结合专家委员会.抗肿瘤药物引起骨髓抑制中西医结合诊治专家共识[J].临床肿瘤学杂志,2021, 26(11):1020-1027.
[3]孙千惠,朱广辉,许博文,等.基于气陷理论探析恶性肿瘤术后中医药治疗与康复思路[J].中医杂志,2024, 65(11):1120-1125.
[4]黄海波.释“营”与“荣”[J].中医药文化,2007(5):42-43.
[5]臧敏,包素珍.《黄帝内经》荣气与营气辨析[J].浙江中医杂志,2019, 54(4):252-253.
[6]Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage ⅠA or ⅠB gastric cancer(JCOG0912):a multicentre,non-inferiority, phase 3 randomised controlled trial[J].Lancet Gastroenterol Hepatol, 2020, 5(2):142-151.
[7]陈健民.癌症攻补思维初探[J].医学与哲学,1985(3):41-42.
[8]He Y, Gao S, Jiang L, et al. Changes in gut microbiota after gastric cancer surgery:a prospective longitudinal study[J/OL]. Front Oncol, 2024, 14:1533816. https://pubmed. ncbi. nlm. nih. gov/39911821/.
[9]高颖,杜磊,肖冲,等.化疗药依托泊苷的中医性能探讨[J].湖北中医杂志,2021, 43(4):50-53.
[10]于姣姣,王杰,陈超.化疗引起骨髓抑制的机制及中医药防治的研究进展[J].中国医药导报,2023, 20(22):47-50.
[11]Zhang T, Zhou M, Xiao D, et al. Myelosuppression alleviation and hematopoietic regeneration by tetrahedralframework nucleic-acid nanostructures functionalized with osteogenic growth peptide[J/OL]. Adv Sci(Weinh),2022, 9(27):e2202058. https://pubmed. ncbi. nlm.nih. gov/35882625/.
[12]王艺璇.升陷汤加味治疗气血虚滞型心脏神经症的临床观察[D].长春:长春中医药大学,2020:37.
[13]高雁,侯坤,董向廷,等.香砂六君子汤联合化疗对晚期胃癌患者KPS评分及生存周期的影响[J].世界中西医结合杂志,2022, 17(10):2019-2023.
[14]许博文,王贺平,李杰,等.李杰教授病症结合治疗肿瘤常用药对[J].世界中医药,2021, 16(20):3078-3081.
[15]张米玲,王珂,左菊萍.复方丹参饮联合化疗对急性髓系白血病患者骨髓抑制、免疫系统的影响[J].医学临床研究,2018, 35(1):111-113.
[16]单鸣秋,陈星,李娟,等.茜草与茜草炭对大鼠急性血瘀模型的影响比较研究[J].中国中药杂志,2014,39(3):493-497.
基本信息:
DOI:10.13288/j.11-2166/r.2026.17.017
中图分类号:R273
引用信息:
[1]成泽润,孙玉婷,张文康,等.从脾、荣气、骨髓的关系论治胃癌术后化疗致骨髓抑制[J].中医杂志,2026,67(17):1910-1914.DOI:10.13288/j.11-2166/r.2026.17.017.
基金信息:
北京市卫生健康委员会2025年度“高创计划·登峰青苗春蕾”项目(G202514019); 中国中医科学院广安门医院护航工程(骨干人才培育项目)(GAMHH9325004); 中国中医科学院基本科研业务费新入职青年科研人员培养专项(ZZ17-XRZ-026);中国中医科学院研究生科技创新项目(KC2025006)
2026-09-01
2026-09-01